Welcome to the 2nd Process Development for Cell Therapies Summit: Driving Process Automation, Affordability and Scalability for Global Cell Therapies

Join 80+ experts from BMS, Janssen, ArsenalBio, Bluebird Bio, Notch Therapeutics, Bayer, and more, looking to streamline cell therapy process development by sharing best practices and pre-competitive learnings to supercharge your pipeline development.

This is your opportunity to engage with the process development for the cell therapy industry, gain insights into best practices, and progress in a pre-competitive space.

. REVIEW The Challenges, Roles and Emerging Trends in Process Development for Cell Therapies with Janssen, 2Seventy Bio and Immatics Biotechnology

. INNOVATE analytical methods and digital platforms to ensure product quality and efficacy with Arsenal Bio and Caribou Biosciences

. OPTIMIZE scalability in an automated approach to reduce human error throughout phase development with Bayer and Glycostem Therapeutics

. MINIMIZE the time of process while maximizing quality of yield with Bristol Myers Squibb and Carisma Therapeutics

. EXAMINE the technical advancements required to drive process development forward in both upstream and downstream processes with Notch Therapeutics and Tmunity Therapeutics

Join us June 20-22, 2023 in Boston, MA!

Read on process-development-celltx.com

Continue reading at process-development-celltx.com

Biosimilar Pharmaceuticals Drug Development

Facebook Share

Twitter Share

Linkedin Share

Email Share